Background Sarcopenia is a geriatric syndrome with progressive loss of skeletal muscle
mass and function and has a negative impact on clinical outcomes associated with chronic …

Sarcopenia (loss of muscle mass and function) implies a worse prognosis. However, its
diagnosis is complex and is not made in routine clinical care. A biomarker has been …

OBJECTIVE: The aim of this study was to examine the effects of sarcopenia on clinical
characteristics and short-term outcomes in elderly chronic obstructive pulmonary disease …

Background & aims Sarcopenia is common in patients with chronic obstructive pulmonary
disease (COPD). Serum creatinine/cystatin C (Cr/CysC) ratio has attracted attention as a …

Background: In chronic obstructive pulmonary disease (COPD), low muscle mass has been
associated with several clinical outcomes such as low exercise capacity, hospital admission …

Background and aims Besides pulmonary dysfunctions, patients with chronic obstructive
pulmonary disease (COPD) also frequently have systemic comorbidities. Among these …

Background and aims Sarcopenia has been reported to be a prognostic factor for chronic
obstructive pulmonary disease (COPD). However, the relationship between the ratio of …

Background The sarcopenia index (SI, serum creatinine/serum cystatin C× 100) is
recommended for predicting sarcopenia. There were several studies showing that lower SI …

Background Increasing evidence suggests that sarcopenia and a higher systemic immune-
inflammation index (SII) are linked with morbidity in patients with COPD. However, whether …

Purpose To investigate the association of sarcopenia index (SI)[(serum creatinine/serum
cystatin C)× 100] with mortality, nutritional risk/malnutrition and sarcopenia among …